|
Covidien Gets Warning Letter After No CAPA Investigations Found
Covidien’s January recall of a surgical staple product hasn’t ended the company’s troubles, as an FDA warning letter questioning Covidien’s handling of safety concerns makes clear.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives